[Ca2+]i and PKC-α are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro-Reference-Cited by-同舟云学术

[Ca2+]i and PKC-α are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro

Published:2007-12 Issue:1 Volume:364 Page:118-123
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Wang Yu,Wang Wei,Wang Qiujuan,Wu Jinhui,Xu Jinyi,Wu Xiaoming

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference29 articles.

1. Converting-enzyme inhibitors in the treatment of hypertension;Williams;N. Engl. J. Med.,1988

2. Angiotensin-converting enzyme inhibitors;Brown;Circulation,1998

3. Pharmacology of angiotensin receptors and AT1 receptor blockers;Chung;Basic Res. Cardiol.,1998

4. Angiotensin receptor blockers: evidence for preserving target organs;Carson;Clin. Cardiol.,2001

5. Comparison of angiotensin II receptor antagonists;Kirch;Eur. J. Clin. Invest.,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irisin attenuates vascular remodeling in hypertensive mice induced by Ang II by suppressing Ca²⁺-dependent endoplasmic reticulum stress in VSMCs;International Journal of Biological Sciences;2024

2. Atypical Kinetics and Albumin Effect of Glucuronidation of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5- yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6- dichlorophenyl)-3H-1,2,4-triazol-3-one, a Novel Nonpeptide Angiotensin Type 1 Receptor Antagonist, in Liver Microsomes and UDP-Glucuronosyl-transferase;Molecules;2018-03-19

3. DL0805-2, a novel indazole derivative, relaxes angiotensin II-induced contractions of rat aortic rings by inhibiting Rho kinase and calcium fluxes;Acta Pharmacologica Sinica;2016-04-04

4. Autoantibodies against β1 Receptor and AT1 Receptor in Type 2 Diabetes Patients with Left Ventricular Dilatation;Cardiology;2014

5. Biological Evaluation of a Novel Angiotensin II AT₁ Receptor Antagonist with Anti-Hypertensive and Anti-Tumor Effects;Advanced Materials Research;2013-09